Targeted breast screening could reduce overdiagnosis and be more cost effective, study finds

Specific PHGKB|Cancer|PHGKB

Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Jul 07, 2018

---

• Targeted breast screening could reduce overdiagnosis and be more cost effective, study finds  
  BMJ News, July 2018
• Broadening the View of Germline Mutations in Kidney Cancer  
  PG Pilie et al, JAMA Oncology, July 5, 2018
• Genetic screening can inform women of their breast and ovarian cancer risks  
  L Abaid, LA Times, July 5, 2018
• Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma  
  MI Carlo et al, JAMA Oncology, July 5, 2018
• Skin Cancer Prevention Progress Report
  CDC, 2018
• Surgeons Influence Receipt of Genetic Testing After Breast Cancer Diagnosis  
  N Fawcett, University of Michigan Health Lab Blog, July 3, 2018
• Using Genetic Risk Scores in Cancer Screening: Are We There Yet? 
  Roberts M et al, CDC Blog Post, July 5, 2018
• Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer A Life-Table Model  
  N Pashayan et al, JAMA Oncology, Juy 5, 2018
• Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection.  
  Abbosh Christopher et al. Nature reviews. Clinical oncology 2018 Jul
• Implementation Challenges for Risk-Stratified Screening in the Era of Precision Medicine  
  MC Roberts, JAMA Oncology, July 5, 2018